Last reviewed · How we verify

NCT05026554

Characterization of Chronic Hand Eczema

Recruiting now Last updated 9 April 2026
What this trial tests

trial testing Tape stripping in Chronic Hand Eczema in 270 participants. Currently enrolling.

Timeline
30 June 2021
Primary endpoint
30 June 2027
30 September 2027

Quick facts

Lead sponsorDr. Robert Bissonnette
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment270
Start date30 June 2021
Primary completion30 June 2027
Estimated completion30 September 2027
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Dr. Robert Bissonnette

Who can join

Adults 18 to 65, any sex, with Chronic Hand Eczema or Atopic Dermatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective longitudinal study to characterize Choronic Hand Eczema (CHE) subtypes and Atopic Dermatitis (AD) with noninvasive molecular and imaging techniques, and assess changes through time and its association with quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Tape stripping

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05026554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing